Iovance Biotherapeutics IOVA
NASDAQ IOVA
$8.09 +0.01 (+0.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Iovance Biotherapeutics (IOVA) Net Long-Term Debt Issued (Repaid) (2011 - 2021)

Updated

Iovance Biotherapeutics' Non-Current Debt came in at $1 million for Q4 2024, unchanged from $1 million a year earlier.

Analysis

Iovance Biotherapeutics (IOVA) Net Long-Term Debt Issued (Repaid) (2011 - 2021) Analysis & Trends

Going back to Q3 2012, Iovance Biotherapeutics' Non-Current Debt data covers 15 quarters.

  • Non-Current Debt carries a three-year compound annual growth rate of 0.0% (FY2021 to FY2024).
  • Going back by year, Non-Current Debt was $1 million in FY2023 (unchanged), $1 million in FY2022 (unchanged) and $1 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Iovance Biotherapeutics 3.74 Bn 2.45 Bn 73.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 1.00 Mn
Jun 30, 2014 -4.93 Mn
Mar 31, 2014 4.93 Mn
Dec 31, 2013 -500.00
Sep 30, 2013 4.93 Mn
Jun 30, 2013 4.93 Mn
Mar 31, 2013 300,000.00
Sep 30, 2012 -1.22 Mn
Jun 30, 2012 4.62 Mn
Dec 31, 2011 2.32 Mn
API Access

Iovance Biotherapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=IOVA&period=max&api_key=YOUR_API_KEY